This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
As we gear up to host you virtually at our “ASH 2020 Comes to You!” Ed Forum on February 4, here are a few words to explain the excitement. Register here!
What is ASH?
The American Society of Hematology is a non-profit organization whose membership includes blood cancer physicians, researchers and healthcare stake holders. It is the world leader in promoting and supporting clinical and scientific hematology research. The ASH Annual December Meeting provides a prestigious forum for the presentation of peer-reviewed abstracts that deliver ground-breaking, cutting-edge data. In this video, Dr. John Pagel emphatically states that this data should be known by all CLL patients and their caregivers to help in advocating for the best possible care for their CLL.
Upcoming Ed Forum on February 4
“ASH 2020 Comes to You!” (10:00 AM PT, 11:00 AM MT, 12:00 PM CT, 1:00 PM ET) Each year, Dr. Koffman and our Medical Advisory Board sift through hundreds of CLL-related ASH Annual Meeting abstracts to bring the most relevant new data to our readers in the form of articles, video interviews, and of course this Ed Forum. So, let’s make certain everyone is registered early for easy entry on Feb. 4 when “ASH 2020 Comes to You!”. Early registration gives you an opportunity to reflect, submit questions in advance, and to receive an event reminder. Highlights will include Dr. Anthony Mato explaining the excitement around LOXO-305, updates from the inform CLL Registry which validates CLL Society’s Test Before Treat™ campaign, and a one pill triple combination therapy targeting Richter Transformation. Dr. William Wierda will discuss the TRANSCEND Study using Liso-cel (JCAR017) in combination with ibrutinib, as well as present updated data from the MRD Cohort of the CAPTIVATE Study. And there will be much more! Don’t miss it. Register here
It’s Good Deed Day at the CLL Society and we are asking you to “Click, fill, send!” Help our susceptible, immune suppressed community become vaccinated ASAP. Throughout this pandemic we have felt helpless, but now there is something we can do to help CLL and other cancer patients move to the front of the COVID-19 vaccine line in your state. CLL Society has called the health departments in all 50 states + DC so you can find out immediately (accurate as of this posting) through our nifty link if your state has already prioritized cancer patients. If your state has not, our letter asking your state’s health department to move cancer patients to the front of the vaccine line is completely prepared for you. So, “Click, fill, send!” that letter. The life you save may be your own. Stay strong. We are all in this together.
Dr. Matthew Davids discusses the impact of COVID-19on clinical practice and reflects on some alterations in the normal routines CLL patients and their physicians are accustomed to. Mentioned are telemedicine appointments, how lab work and scans are being done, which patients are high priority for in-office visits, updates on clinical trial procedures and more. Learn more here.
ASH 2020 Dr. Anthony Mato discusses the Once Daily, Oral Triple Therapy Clinical Trial for Richter’s Transformation and De Novo Large B-Cell Lymphoma. This clinical trial introduces the concept of “synthetic lethality,” where multiple targeted agents are used at low dosages to block different pathways, and achieve the ability to kill cancer cells without the associated toxicities of using three drugs together at their usual dosages. Learn more here.
ASH 2020 Dr. William Wierda, many CLL experts believe that Dr. Wierda’s exciting oral presentation on the success of combining the CAR-T liso-cel with ibrutinib could be the harbinger of a new era in how we will treat CLL in the near future. Watch our interview with Dr. Wierda here.
If you haven’t yet registered to join one of our 38 CLL-specific monthly Support Groups, try it! If you have fallen out of the habit of attending one you have participated in before, then welcome back! No need to be alone and no need to ever be out of the information loop. The CLL Society is here to help. Check out this interview with CLL Society’s Director of Support Groups, a 20-year CLL survivor, and find out what you’re missing or remember how good it was. Then register to attend a meeting. You will be glad you did!
Quick links to great help from the CLL Society
New to CLL? Dr. Neil Kay leads the way!
CLL Support Groups, here is THE BIG MAP:
We are celebrating 10 Years of covering ASH (and all the other major hematology conferences) to bring you the most important, breaking CLL research news in patient-friendly terms. Support the ongoing work of the CLL Society. Please donate today. Thank you!
CLL Society is the only CLL-specific, physician-curated public charity dedicated to meeting the unmet needs of CLL patients and their caregivers which holds the GuideStar Platinum Seal of Transparency.
We are all in this together.
Co-Founder & Communications Director
CLL Society Support Group Meetings Coming Up!
CLL Society Support Group meetings have moved to a virtual platform for most locations due to the threat of coronavirus. Support group members will receive an invitation to register for the meeting from the support group facilitator. If you are new to the group, please contact the RSVP email for the Support Group in your region. Once it is safe again, we will resume in-person meetings.
Visit the individual event listings on our website for the most up-to-date information on all CLL Society Support Group meetings.